{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T18:16:16Z","timestamp":1780856176785,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00393-006-0039-2","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:59:16Z","timestamp":1139407156000},"page":"32-44","source":"Crossref","is-referenced-by-count":5,"title":["M. Gaucher, M. Fabry und Mukopolysaccharidose Typ I","Gaucher disease, Fabry disease and mucopolysaccharidosis type I \u2013 How can the rheumatologist recognise these patients?"],"prefix":"10.1007","volume":"65","author":[{"given":"B.","family":"Manger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"39_CR1","unstructured":"Aghion H (1934) La maladie de Gaucher dans l\u2019enfance: forme cardiorenale. Paris: Faculte de Medecine de Paris"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s002470050340","volume":"28","author":"Allison","year":"1998","unstructured":"Allison JW, James CA, Arnold GL et al (1998) Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR. Pediatr Radiol 28:237\u2013240","journal-title":"Pediatr Radiol"},{"key":"39_CR3","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","volume":"324","author":"Barton","year":"1991","unstructured":"Barton NW, Brady RO, Dambrosia JM et al (1991) Replacement therapy for inherited enzyme deficiency \u2013 macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease. N Engl J Med 324:1464\u20131470","journal-title":"N Engl J Med"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","volume":"18","author":"Brady","year":"1965","unstructured":"Brady RO, Kanfer JN, Shapiro D (1965) Metabolism of Glucocerebrosides. II. Evidence of an Enzymatic Deficiency in Gaucher\u2019s Disease. Biochem Biophys Res Commun 18:221\u2013225","journal-title":"Biochem Biophys Res Commun"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM et al (1967) Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency. N Engl J Med 276:1163\u20131167","journal-title":"N Engl J Med"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0300-9084(72)80173-1","volume":"54","author":"Brady","year":"1972","unstructured":"Brady RO (1972) Lipidoses. Biochimie 54:723\u2013733","journal-title":"Biochimie"},{"key":"39_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1651-2227.1995.tb13640.x","volume":"84","author":"Cleary","year":"1995","unstructured":"Cleary MA, Wraith JE (1995) The presenting features of mucopolysaccharidosis type IH (Hurler syndrome). Acta Paediatr 84:337\u2013339","journal-title":"Acta Paediatr"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","volume":"355","author":"Cox","year":"2000","unstructured":"Cox T, Lachmann R, Hollak C et al (2000) Novel oral treatment of Gaucher\u2019s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 355:1481\u20131485","journal-title":"Lancet"},{"key":"39_CR9","unstructured":"Desnick RJ, Ioannou Y, Eng CM (2001) Alpha-Galactosidase A deficiency: Fabry disease. In: Scriver C, Beaudet A, Sly W, Valle D (Hrsg) The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, pp\u00a03733\u20133774"},{"key":"39_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013346","journal-title":"Ann Intern Med"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR et al (2001) Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry\u2019s disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"39_CR12","doi-asserted-by":"crossref","DOI":"10.1007\/BF01986897","volume":"43","author":"Fabry","year":"1898","unstructured":"Fabry J (1898) Ein Beitrag zur Kenntnis der purpura haemorrhagica nodularis. Arch Dermatol Syph 43","journal-title":"Arch Dermatol Syph"},{"key":"39_CR13","unstructured":"Gaucher P (1882) De l\u2019epithelioma primitif de la rate, hypertrophie idiopathique de la rate sans leucemie (doctoral thesis). Paris"},{"key":"39_CR14","first-page":"792","volume":"85","author":"Giraldo","year":"2000","unstructured":"Giraldo P, Pocovi M, Perez-Calvo J et al (2000) Report of the Spanish Gaucher\u2019s disease registry: clinical and genetic characteristics. Haematologica 85:792\u2013799","journal-title":"Haematologica"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0925-4439(03)00129-7","volume":"1639","author":"Hein","year":"2003","unstructured":"Hein LK, Hopwood JJ, Clements PR, Brooks DA (2003) The alpha-L-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation. Biochim Biophys Acta 1639:95\u2013103","journal-title":"Biochim Biophys Acta"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"Hollak","year":"1994","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288\u20131292","journal-title":"J Clin Invest"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02222956","volume":"24","author":"Hurler","year":"1919","unstructured":"Hurler G (1919) \u00dcber einen Typ multipler Abartungen, vorwiegend am Skelettsystem. Z Kinderheilk 24:220","journal-title":"Z Kinderheilk"},{"key":"39_CR18","first-page":"158","volume":"2","author":"Kauli","year":"2000","unstructured":"Kauli R, Zaizov R, Lazar L et al (2000) Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and\/or enzyme replacement therapy. Isr Med Assoc J 2:158\u2013163","journal-title":"Isr Med Assoc J"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","volume":"26","author":"Krivit","year":"2004","unstructured":"Krivit W (2004) Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunopathol 26:119\u2013132","journal-title":"Springer Semin Immunopathol"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769\u2013775","journal-title":"J Med Genet"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. Jama 281:249\u2013254","journal-title":"Jama"},{"key":"39_CR22","unstructured":"Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Valle D, Sly W (Hrsg) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp\u00a03421\u20133452"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/PL00002150","volume":"96","author":"Niederau","year":"2001","unstructured":"Niederau C, Rolfs A, vom Dahl S et al (2001) Diagnose und Therapie des Morbus Gaucher. Aktuelle Empfehlungen der deutschen Therapiezentren im Jahr 2000. Med Klin 96:32\u201339","journal-title":"Med Klin"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","volume":"87","author":"Peters","year":"1996","unstructured":"Peters C, Balthazor M, Shapiro EG et al (1996) Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87:4894\u20134902","journal-title":"Blood"},{"key":"39_CR25","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1259\/bjr.75.suppl_1.750025","volume":"75","author":"Poll","year":"2002","unstructured":"Poll LW, Maas M, Terk MR et al (2002) Response of Gaucher bone disease to enzyme replacement therapy. Br J Radiol 75 Suppl 1:A25\u201336","journal-title":"Br J Radiol"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"Poorthuis","year":"1999","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105:151\u2013156","journal-title":"Hum Genet"},{"key":"39_CR27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1148\/radiology.185.3.1438773","volume":"185","author":"Rosenthal","year":"1992","unstructured":"Rosenthal DI, Barton NW, McKusick KA et al (1992) Quantitative imaging of Gaucher disease. Radiology 185: 841\u2013845","journal-title":"Radiology"},{"key":"39_CR28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0002-9394(62)93395-0","volume":"53","author":"Scheie","year":"1962","unstructured":"Scheie H, Hambrick G, Barness L (1962) A newly recognized forme fruste of Hurler\u2019s disease (gargoylism). Am J Ophthalm 53:753\u2013769","journal-title":"Am J Ophthalm"},{"key":"39_CR29","first-page":"388","volume":"106","author":"Shoenfeld","year":"1982","unstructured":"Shoenfeld Y, Gallant LA, Shaklai M et al (1982) Gaucher\u2019s disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106:388\u2013391","journal-title":"Arch Pathol Lab Med"},{"key":"39_CR30","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","volume":"350","author":"Staba","year":"2004","unstructured":"Staba SL, Escolar ML, Poe M et al (2004) Cord-blood transplants from unrelated donors in patients with Hurler\u2019s syndrome. N Engl J Med 350:1960\u20131969","journal-title":"N Engl J Med"},{"key":"39_CR31","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/S0021-9258(18)51888-3","volume":"238","author":"Sweeley","year":"1963","unstructured":"Sweeley CC, Klionsky B (1963) Fabry\u2019s Disease: Classification as a Sphingolipidosis and Partial Characterization of a Novel Glycolipid. J Biol Chem 238:3148\u20133150","journal-title":"J Biol Chem"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","volume":"62","author":"Thurberg","year":"2002","unstructured":"Thurberg BL, Rennke H, Colvin RB et al (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933\u20131946","journal-title":"Kidney Int"},{"key":"39_CR33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1010514614570","volume":"24","author":"Vellodi","year":"2001","unstructured":"Vellodi A, Bembi B, de Villemeur TB et al (2001) Management of neuronopathic Gaucher disease: a European consensus. J Inherit Metab Dis 24:319\u2013327","journal-title":"J Inherit Metab Dis"},{"key":"39_CR34","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","volume":"108","author":"Weidemann","year":"2003","unstructured":"Weidemann F, Breunig F, Beer M et al (2003) Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108:1299\u20131301","journal-title":"Circulation"},{"key":"39_CR35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","volume":"144","author":"Wraith","year":"2004","unstructured":"Wraith JE, Clarke LA, Beck M et al (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144:581\u2013588","journal-title":"J Pediatr"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-006-0039-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0039-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T18:25:00Z","timestamp":1627064700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-006-0039-2"}},"subtitle":["Wie kann der Rheumatologe diese Patienten erkennen?"],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s00393-006-0039-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}